Everolimus
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-10218-50 mg |
| CAS # | 159351-69-6 |
| Pricing | 50 mg, USD $120.0 |
| Synonyms | RAD001; SDZ-RAD |
| MWt | 958.22 |
| Formula | C₅₃H₈₃NO₁₄ |
| Biological Activity | Everolimus (RAD001) is a Rapamycin derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2]. |
| Purity | ≥98.0% |